APPLICATION
ANDA209814
TYPE
ANDA
ROUTE
IV (INFUSION)
DOSAGE FORM
POWDER
MARKETING STATUS
None (Tentative Approval)
Products
BENDAMUSTINE HYDROCHLORIDENone (Tentative Approval)
BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL · POWDER · IV (INFUSION)
BENDAMUSTINE HYDROCHLORIDENone (Tentative Approval)
BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL · POWDER · IV (INFUSION)
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.